Index -
P/E -
EPS (ttm) -1.00
Insider Own 3.87%
Shs Outstand 11.53M
Perf Week -1.06%
Market Cap 21.56M
Forward P/E -
EPS next Y -
Insider Trans -4.09%
Shs Float 11.09M
Perf Month -16.89%
Income -10.28M
PEG -
EPS next Q -
Inst Own 28.21%
Short Float 0.41%
Perf Quarter -18.70%
Sales 1.30M
P/S 16.59
EPS this Y -
Inst Trans 1.04%
Short Ratio 2.06
Perf Half Y -12.62%
Book/sh 2.54
P/B 0.74
EPS next Y -
ROA -
Short Interest 0.05M
Perf Year -48.20%
Cash/sh 0.38
P/C 4.98
EPS next 5Y 17.60%
ROE -
52W Range 1.86 - 4.72
Perf YTD -16.89%
Dividend Est. -
P/FCF -
EPS past 5Y 49.33%
ROI -28.69%
52W High -60.42%
Beta 1.06
Dividend TTM -
Quick Ratio 1.38
Sales past 5Y 532.80%
Gross Margin 29.19%
52W Low 0.54%
ATR (14) 0.11
Dividend Ex-Date -
Current Ratio 1.38
EPS Y/Y TTM 1.49%
Oper. Margin -654.61%
RSI (14) 28.51
Volatility 3.57% 5.03%
Employees 1
Debt/Eq 0.27
Sales Y/Y TTM -
Profit Margin -789.40%
Recom 3.00
Target Price 5.00
Option/Short Yes / Yes
LT Debt/Eq 0.22
EPS Q/Q 97.55%
Payout -
Rel Volume 0.47
Prev Close 1.92
Sales Surprise -
EPS Surprise -
Sales Q/Q -97.60%
Earnings Mar 29 AMC
Avg Volume 22.30K
Price 1.87
SMA20 -9.74%
SMA50 -16.27%
SMA200 -31.78%
Trades
Volume 10,579
Change -2.60%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-07-20 Downgrade
Jefferies
Hold → Underperform
May-19-20 Downgrade
JP Morgan
Overweight → Neutral
Dec-02-19 Initiated
Guggenheim
Buy
Oct-17-19 Initiated
H.C. Wainwright
Buy
$7
Apr-30-19 Resumed
Noble Capital Markets
Outperform
$13
Jun-15-18 Initiated
JP Morgan
Overweight
$11
Sep-08-17 Initiated
Morgan Stanley
Equal-Weight
$6
Jul-11-17 Upgrade
Oppenheimer
Perform → Outperform
May-09-17 Downgrade
Oppenheimer
Outperform → Perform
Nov-22-16 Resumed
Jefferies
Buy
$18
Nov-22-16 Initiated
Oppenheimer
Outperform
Nov-07-16 Resumed
Guggenheim
Buy
Apr-04-16 Initiated
Goldman
Buy
$10
Dec-08-15 Reiterated
Stifel
Buy
$10 → $14
Dec-08-15 Reiterated
Jefferies
Buy
$15 → $18
Sep-21-15 Reiterated
Jefferies
Buy
$7 → $15
Jun-09-15 Initiated
Guggenheim
Buy
Jul-08-14 Initiated
FBR Capital
Outperform
$34
Apr-17-14 Reiterated
Noble Financial
Buy
$9 → $13
Jan-28-14 Reiterated
Noble Financial
Buy
$7.25 → $9
Show Previous Ratings
Mar-29-24 04:00PM
Mar-12-24 11:40AM
Jan-30-24 11:20PM
Nov-15-23 05:08AM
(Associated Press Finance) +17.41%
Nov-14-23 04:05PM
07:52AM
Loading…
Aug-14-23 07:52AM
(Associated Press Finance)
06:50AM
May-15-23 05:56PM
04:05PM
Apr-14-23 12:00PM
Apr-07-23 04:01PM
Jan-03-23 06:50AM
Dec-08-22 10:42AM
(American City Business Journals)
Dec-04-22 06:00PM
Nov-14-22 07:55PM
04:05PM
Loading…
04:05PM
Oct-31-22 06:50AM
Oct-03-22 01:45PM
(American City Business Journals) -7.53%
06:50AM
Sep-12-22 06:50AM
Aug-15-22 01:00PM
08:05AM
06:50AM
Aug-08-22 06:50AM
Aug-01-22 01:00PM
(American City Business Journals) +36.60%
06:50AM
Jul-15-22 01:34PM
Jul-13-22 09:48AM
08:25AM
06:50AM
06:09AM
Loading…
Jul-06-22 06:09AM
Jun-06-22 04:05PM
May-31-22 06:00AM
May-20-22 10:52AM
09:43AM
May-16-22 08:00PM
05:45PM
04:05PM
May-12-22 05:25PM
May-10-22 04:05PM
Apr-14-22 04:15PM
Mar-10-22 01:30PM
08:05AM
06:50AM
Mar-07-22 12:57PM
07:40AM
Mar-01-22 04:30PM
Feb-28-22 05:35PM
Feb-24-22 09:05AM
Jan-25-22 08:52AM
Jan-06-22 07:29AM
Jan-04-22 06:20AM
Dec-28-21 09:53AM
Dec-13-21 06:08AM
Dec-10-21 04:30PM
Dec-08-21 06:50AM
Nov-24-21 07:54AM
Nov-22-21 10:40AM
Nov-12-21 03:00AM
Nov-11-21 06:50AM
06:45AM
Nov-04-21 03:01PM
Oct-27-21 05:00PM
Oct-15-21 05:33PM
Oct-05-21 01:28PM
Oct-04-21 09:20AM
Sep-02-21 06:50AM
Aug-23-21 06:50AM
Aug-19-21 08:01AM
Aug-09-21 04:30PM
Aug-04-21 08:05AM
06:50AM
Jul-28-21 03:03PM
Jul-26-21 06:50AM
Jul-06-21 11:49AM
Jun-29-21 08:58AM
May-25-21 06:50AM
May-24-21 07:00AM
May-07-21 01:31AM
May-06-21 10:56AM
08:20AM
07:00AM
06:45AM
May-03-21 07:00AM
Apr-29-21 10:34AM
07:00AM
Apr-28-21 12:34PM
Apr-09-21 11:16AM
05:05AM
Apr-08-21 04:05PM
Mar-15-21 10:32AM
Mar-02-21 07:00PM
08:25AM
07:22AM
07:00AM
06:30AM
Mar-01-21 10:05AM
07:00AM
Feb-23-21 04:05PM
Feb-18-21 10:16AM
(Yahoo Finance Video) -5.41%
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walker Marlan D Chief Executive Officer Dec 07 '23 Sale 2.24 4,550 10,187 62,565 Dec 07 04:51 PM Walker Marlan D Chief Executive Officer Dec 06 '23 Sale 2.31 14,500 33,496 67,115 Dec 07 04:51 PM Walker Marlan D Chief Executive Officer Dec 05 '23 Option Exercise 0.00 70,000 0 81,615 Dec 07 04:51 PM
Index RUT
P/E -
EPS (ttm) -2.28
Insider Own 8.63%
Shs Outstand 27.31M
Perf Week -3.05%
Market Cap 507.56M
Forward P/E 21.09
EPS next Y 0.86
Insider Trans -0.84%
Shs Float 25.57M
Perf Month -6.11%
Income -64.30M
PEG -
EPS next Q -0.45
Inst Own 81.17%
Short Float 2.21%
Perf Quarter -31.16%
Sales 2.82B
P/S 0.18
EPS this Y -332.94%
Inst Trans -4.02%
Short Ratio 2.37
Perf Half Y -25.26%
Book/sh 30.18
P/B 0.60
EPS next Y 143.43%
ROA -3.63%
Short Interest 0.56M
Perf Year -38.49%
Cash/sh 0.48
P/C 37.43
EPS next 5Y 10.00%
ROE -7.23%
52W Range 16.90 - 36.64
Perf YTD -39.85%
Dividend Est. 0.75 (4.13%)
P/FCF -
EPS past 5Y -
ROI -4.91%
52W High -50.49%
Beta 1.63
Dividend TTM 0.75 (4.13%)
Quick Ratio 0.92
Sales past 5Y 8.12%
Gross Margin 9.41%
52W Low 7.34%
ATR (14) 0.97
Dividend Ex-Date Apr 19, 2024
Current Ratio 1.96
EPS Y/Y TTM -189.47%
Oper. Margin 0.43%
RSI (14) 43.16
Volatility 3.52% 5.45%
Employees 3353
Debt/Eq 0.58
Sales Y/Y TTM -13.43%
Profit Margin -2.28%
Recom 4.00
Target Price 17.00
Option/Short Yes / Yes
LT Debt/Eq 0.55
EPS Q/Q -885.14%
Payout -
Rel Volume 1.49
Prev Close 17.91
Sales Surprise -0.84%
EPS Surprise 5.02%
Sales Q/Q -17.84%
Earnings Apr 04 BMO
Avg Volume 238.18K
Price 18.14
SMA20 -4.98%
SMA50 -10.19%
SMA200 -30.73%
Trades
Volume 354,897
Change 1.28%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-28-24 Downgrade
Seaport Research Partners
Neutral → Sell
$17.50
Dec-14-23 Initiated
Seaport Research Partners
Neutral
May-19-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Mar-24-22 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$58
Jul-19-21 Initiated
Northland Capital
Outperform
$80
Apr-09-21 Initiated
Goldman
Buy
$48
Jan-12-21 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Nov-20-20 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$28
Oct-10-19 Reiterated
Cowen
Market Perform
$22 → $21
Sep-23-19 Downgrade
Goldman
Neutral → Sell
$27 → $23
Jun-25-19 Reiterated
Cowen
Market Perform
$24 → $25
Jan-14-19 Downgrade
Goldman
Buy → Neutral
Jan-09-19 Initiated
Cowen
Market Perform
$24
Aug-15-18 Downgrade
Morgan Stanley
Equal-Weight → Underweight
Mar-20-18 Initiated
Goldman
Buy
$42
Sep-07-17 Initiated
Macquarie
Neutral
Apr-01-16 Reiterated
DA Davidson
Neutral
$15 → $18
Nov-24-15 Upgrade
Morgan Stanley
Underweight → Equal-Weight
Jul-01-15 Upgrade
BofA/Merrill
Underperform → Buy
Jan-05-15 Downgrade
DA Davidson
Buy → Neutral
$34 → $25
Show Previous Ratings
Apr-16-24 09:00AM
Apr-08-24 09:10AM
Apr-05-24 05:48PM
Apr-04-24 09:31AM
08:00AM
10:58AM
Loading…
Mar-18-24 10:58AM
Mar-14-24 04:35PM
Mar-09-24 07:48AM
Mar-04-24 08:30AM
Jan-06-24 08:07AM
Jan-05-24 01:20AM
(Thomson Reuters StreetEvents)
Jan-04-24 03:06PM
08:17AM
(Associated Press Finance)
08:00AM
Dec-18-23 09:00AM
09:15AM
Loading…
Dec-13-23 09:15AM
Nov-16-23 08:30AM
Oct-26-23 10:01AM
01:25AM
(Thomson Reuters StreetEvents)
Oct-25-23 09:43AM
08:26AM
(Associated Press Finance)
08:00AM
Sep-29-23 08:30AM
Aug-30-23 08:00AM
Aug-10-23 05:31PM
(American City Business Journals)
Jul-26-23 05:45PM
(American City Business Journals)
04:00PM
Jul-04-23 07:33AM
Jun-30-23 12:48PM
06:12AM
07:29AM
Loading…
Jun-29-23 07:29AM
(Investor's Business Daily)
Jun-28-23 04:43PM
(Investor's Business Daily)
04:13PM
(Investor's Business Daily)
03:30PM
(Investor's Business Daily)
02:18AM
(Thomson Reuters StreetEvents)
Jun-27-23 04:09PM
(Investor's Business Daily)
08:13AM
08:00AM
Jun-26-23 04:07PM
(Investor's Business Daily)
Jun-23-23 06:46PM
(Investor's Business Daily)
03:01PM
(Investor's Business Daily)
Jun-21-23 08:45AM
Jun-18-23 10:02AM
Jun-12-23 08:30AM
Jun-03-23 09:01AM
May-19-23 09:20AM
May-05-23 08:41AM
Apr-14-23 09:30AM
Apr-10-23 08:45AM
Apr-08-23 08:20AM
Apr-07-23 12:22AM
Apr-05-23 08:21AM
08:00AM
Mar-28-23 09:40AM
Mar-20-23 06:00PM
05:00PM
Mar-16-23 08:34AM
Mar-13-23 07:00AM
Mar-10-23 06:00PM
Feb-28-23 06:00PM
Feb-22-23 06:00PM
Feb-14-23 06:00PM
Jan-30-23 02:38PM
Jan-22-23 07:19AM
Jan-18-23 07:30AM
01:03AM
Jan-10-23 06:50AM
Jan-09-23 07:18AM
Jan-08-23 07:17AM
Jan-05-23 08:00AM
Jan-03-23 09:40AM
Jan-02-23 05:53AM
Dec-29-22 10:00AM
Dec-26-22 09:40AM
Dec-19-22 04:30PM
Dec-16-22 07:29AM
Dec-15-22 08:30AM
Dec-12-22 10:24AM
Nov-25-22 01:42PM
Nov-16-22 10:25AM
Nov-14-22 08:30AM
Nov-05-22 08:19AM
Oct-27-22 06:41AM
Oct-24-22 08:00AM
Oct-20-22 10:02AM
Oct-17-22 10:00AM
Oct-12-22 09:00AM
08:26AM
Oct-07-22 07:58AM
Oct-04-22 06:30PM
Aug-01-22 06:17PM
(American City Business Journals)
08:30AM
Jul-20-22 08:56AM
Jul-07-22 08:54AM
Jul-02-22 08:18AM
Jun-29-22 10:01AM
09:15AM
08:00AM
Jun-24-22 09:33AM
Jun-14-22 03:32PM
Radius Recycling, Inc. engages in the recycling of ferrous and nonferrous scrap metal and manufacture of finished steel products. The company was founded by Sam Schnitzer in 1906 and is headquartered in Portland, OR.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Souza Brian SVP, Chief Ops Mgmt Officer Nov 10 '23 Sale 23.49 4,500 105,705 18,767 Nov 14 07:13 PM Heiskell Steven SVP & President, Recycling P&S Nov 07 '23 Sale 24.14 8,000 193,120 136,367 Nov 08 06:50 PM Vaughn James Matthew SVP, GC, CCO, Corp. Secretary Nov 06 '23 Sale 24.83 571 14,178 6,608 Nov 07 01:42 PM Gaggini Stefano R. SVP, CFO Nov 03 '23 Sale 24.86 7,269 180,707 63,295 Nov 07 01:35 PM Heiskell Steven SVP, Products & Services May 05 '23 Sale 28.64 1,649 47,227 131,523 May 09 12:17 PM Henderson Michael R SVP, President, Operations May 04 '23 Sale 27.44 1,691 46,401 132,769 May 08 10:28 AM Gaggini Stefano R. SVP, CFO May 03 '23 Sale 28.43 1,026 29,164 62,374 May 05 12:15 PM Schuessler Mark VP and CAO May 03 '23 Sale 28.51 157 4,476 7,730 May 05 12:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite